Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Apomorphine-induced Skin Reactions: a Pilot Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Female and male subjects aged ≥30;~* Diagnosis of idiopathic Parkinson's disease of \>3 years' duration, defined by the United Kingdom (UK) Brain Bank criteria, with the exception of \>1 affected relative being allowed, without any other known or suspected cause of Parkinsonism (Gibb \& Lees, 1988);~* Treatment with continuous subcutaneous apomorphine infusion;~* Having apomorphine-induced skin reactions (i.e. erythema, swelling and/or nodule formation);~* Male and female patients must be compliant with a highly effective contraceptive method (oral hormonal contraception alone is not considered highly effective and must be used in combination with a barrier method) during the study, if sexually active;~* Subjects considered reliable and capable of adhering to the protocol, visit schedule, and medication intake according to the judgement of the investigator.~Exclusion Criteria:~* High suspicion of other parkinsonian syndromes;~* History of respiratory depression;~* Hypersensitivity to hydrocortisone or any excipients of the medicinal product;~* Concomitant therapy with histamine antagonist;~* Known with Cushing's disease or hypercortisolism~* Any medical condition that is likely to interfere with an adequate participation in the study including e.g. current diagnosis of unstable epilepsy; clinically relevant cardiac dysfunction and/or myocardial infarction or stroke within the last 12 months;~* Pregnant and breastfeeding women;~* Current infectious disease with fever at the time of investigation.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Massage with a spiky ball (Type: ACTIVE_COMPARATOR): Subjects are instructed to massage the apomorphine-induced skin reactions with a spiky ball 3 times a day for 2 minutes for 14 days.
- Hydrocortisone cream 1% (Type: ACTIVE_COMPARATOR): Subjects are instructed to apply hydrocortisone cream 1% once daily for 14 days.
- Subcutaneous hydrocortisone 10mg (Type: ACTIVE_COMPARATOR): Subjects are instructed to administer subcutaneous hydrocortisone (Solu-Cortef 10mg) prior to apomorphine via the subcutaneous infusion line which is used for administration of apomorphine, for 14 days.
- Apomorphine 0.25% (2.5mg/ml) (Type: ACTIVE_COMPARATOR): Subjects are instructed to dilute apomorphine 0.5% (5mg/ml) with the same volume of physiologic saline (NaCl 0.9%) to 0.25% (2.5mg/ml). Apomorphine will be infused subcutaneously for 14 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).